 |
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
||
 |
 |
 |
|
|||||||
 |
|
|||||||||
 |
|
|||||||||
Alert Number 281
Date: March 8, 2024
Back in January 2024 we wrote about a clinical trial that we helped sponsor and fund – combination of Rituxan and Fenretinide (an analog of vitamin A) – at the Fred Hutchinson Cancer Center. Your hard earned dollars paid for the grant we gave Dr. Ajay Gopal, the PI of this trial. For those of you who are not familiar with this trial and its potential for giving Rituxan a low toxicity ‘oomph’, here is the link to our earlier article where we described it and the basis of our interest in it.
Rituxan + Fenretinide Clinical Trial
This Alert is to bring you some recent information about this trial. Richard Warburton is a good friend and valued member of our CLL patient community. Richard is also a participant in the Rituxan + Fenretinide clinical trial. Richard decided he wanted to share his experience with this combination with the rest of you. He also decided to include his actual name and contact information, for those of you who may be interested in participating in this trial and would like to contact him with additional questions. Below are Richard’s comments, verbatim, I did not make any changes in his narrative. Please join me in thanking Richard for his generosity, and wish him continued success with the R + Fenretinide trial. Way to go, Richard!!
A Patient Perspective - R + Fenretinide
One additional point: in a recent exchange of emails Dr. Gopal told me that their Internal Review Board now allows patients go get the Rituxan part of the combination at their local oncologist’s office, which may make it easier for patients coming from out of town or out of state.
Be well,
Chaya
NOTICE: This page from the Topics Alert archive was originally emailed to subscribers of Topics Alert, a free service of CLL Topics Inc. If you are not a subscriber and you wish to receive email Alerts, please register at the Topics Alert subscription page. The content of this page is intended for information only and it is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
———
Disclaimer: The content of this website is intended for information only and is NOT meant to be medical advice. Please be sure to consult and follow the advice of your doctors on all medical matters.
Copyright Notice:
Copyright © 2024-2007 CLL Topics, Inc. All Rights Reserved.
All materials contained on this site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of CLL Topics, Inc. You may not alter or remove any trademark, copyright or other notice from copies of the content.
However, you may download and print material from CLLTopics.org exclusively for your personal, noncommercial use.
———
